| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030216 Peptoids incorporating chemoselective functionalities |
| 04/13/2006 | WO2005116255A3 Aptamer-toxin molecules and method for using same |
| 04/13/2006 | WO2005103698A3 Methods and antibodies for nitrofuran detection |
| 04/13/2006 | US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | CN1757662A Interpenetrating network polymer type super porous aquogel, its prepn. method and application |
| 04/12/2006 | CN1250565C Synthesis of protein by natural chemical ligation |
| 04/11/2006 | US7026454 Polypeptide of given sequence that is a biochemical marker for prostate cancer conjugated to an antibody or fragment thereof; treating prostate cancer |
| 04/11/2006 | US7026289 Method and compositions for treating hyperlipidemia and other conditions |
| 04/06/2006 | WO2006026470A3 Hiv immunostimulatory compositions |
| 04/06/2006 | WO2004076621A3 Compositions of nucleic acids for treating and detecting influenza virus |
| 04/06/2006 | US20060074227 Antibodies against PRO Polypeptides which may be overexpressed in tumors |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060073576 envelope proteins (Env) comprising CD4 (and mimetics) binding site and deletion region; maintains structural conformation of complementary determining region 2-like loop; insertion near chemokine receptor binding site; vectors, cells; liposomes |
| 04/06/2006 | US20060073568 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073545 PRO polypeptides and chimeric polypeptides; may be drug target for tumors |
| 04/06/2006 | US20060073544 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/05/2006 | EP1642974A1 Recombinant soluble Fc receptors |
| 04/05/2006 | CN1756761A Target recognizing binding agents |
| 04/05/2006 | CN1754889A Pegylated interferon alpha-1b |
| 04/04/2006 | US7022821 Tumor Antigen Derived Gene-15 (TADG-15); a detectably labeled antibody specific for the TADG-15 protein which has a molecular size of 100 kDa and comprises CUB, LDLR and serine protease domains; useful in the diagnosis or treatment of breast and ovarian cancer in particular |
| 04/04/2006 | US7022817 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/04/2006 | US7022492 Ecstasy haptens and immunogens |
| 04/04/2006 | US7022323 Prevent infections using envelope glycoprotein; binding to antibody |
| 03/30/2006 | US20060068423 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068413 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060068404 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/30/2006 | US20060067885 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell |
| 03/29/2006 | EP1639141A2 Methods for treating lentivirus infections |
| 03/29/2006 | EP1639092A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/29/2006 | EP1638606A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/29/2006 | EP1638443A2 Isoforms of brain natriuretic peptide |
| 03/29/2006 | EP1007554B1 Oil bodies and associated proteins as affinity matrices |
| 03/29/2006 | CN1753724A Peptide mediated synthesis of metallic and magnetic materials |
| 03/29/2006 | CN1247183C Dental products comprising bone growth enhancing peptide |
| 03/28/2006 | US7018851 chelate compounds joined to antibodies, antigens, receptor ligands, binding proteins and DNA or RNA probes, for use in bioassays |
| 03/28/2006 | US7018810 Chordin-like molecules and uses thereof |
| 03/28/2006 | US7018627 administering mammals macrophage derived chemokine(MDC) antagonists comprising monoclonal, polyclonal or single chain antigen binding proteins, to attenuate allergies characterized by eosinophil accumulation |
| 03/23/2006 | WO2004056970A3 Chemo-enzymatic process for proteome-wide mapping of post-translational modification |
| 03/23/2006 | US20060063247 Increased thermostability, photostability, and water solubility |
| 03/22/2006 | EP1637166A2 Virus-like particles for the induction of autoantibodies |
| 03/22/2006 | EP1635692A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 03/22/2006 | CN1246040C Process to make a sustained release formulation |
| 03/21/2006 | US7015313 use as a diagnostic agent or a carrier protein conjugated to various anti-cancer drugs owing to its ability to specifically recognize N-glycolylneuraminic acid; antiproliferative agent; called lectin PPA (Philyra pisum agglutinin) |
| 03/21/2006 | US7015306 Peptide analogs of neurotensin resistant to enzymatic degradation and retain high binding affinity for neurotensin receptors; metal chelating group on one end; replacing Arg8 with Gly(PipAm) ((N-amidinopiperidinyl)glycine) for example; useful for diagnostic and therapeutic purposes |
| 03/21/2006 | US7015034 Materials and procedures for the purification of cells |
| 03/21/2006 | US7014823 comprises two energy transmitting stripes across an ATP well, actin filaments and a movable member coated with myosin that moves linearly as a result of actin/myosin interaction; nanoscale mechanical devices, pumps, valves |
| 03/16/2006 | WO2005117538A9 METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION |
| 03/16/2006 | US20060058506 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 03/16/2006 | US20060057583 Novel compositions and methods for controlling the extendability of various components used in copying or amplification steps |
| 03/15/2006 | EP1634074A2 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 03/15/2006 | EP1633772A2 Aav virions with decreased immunoreactivity and uses therefor |
| 03/15/2006 | EP1633189A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/14/2006 | US7012131 Pro1410 polypeptides |
| 03/14/2006 | US7012127 site-directed mutagenesis; for prevention and treatment of sepsis and other endotoxin-related disorders |
| 03/14/2006 | US7011963 Process for synthesis of bead-shaped cross-linked hydrophilic support polymer |
| 03/14/2006 | CA2324348C Methods and compositions for peptide synthesis |
| 03/14/2006 | CA2298106C A recombinant expression vector of human parathyroid hormone |
| 03/09/2006 | US20060051976 Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics |
| 03/09/2006 | US20060051785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051784 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051750 Method for fixing biomolecule on carrier |
| 03/09/2006 | US20060051333 AAV virions with decreased immunoreactivity and uses therefor |
| 03/08/2006 | EP0728015B1 Method of producing a set of combinatorial polypeptide antigens |
| 03/07/2006 | US7009038 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 03/07/2006 | US7009036 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 03/07/2006 | US7008634 includes growth factors and extracellular matrix molecules flexibly tethered to a support medium; used to stimulate cell and tissue growth by enhancment of the biological response to the growth factor; liver cells |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/02/2006 | US20060047106 Neisseria meningitdis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof |
| 03/02/2006 | CA2576963A1 Sequential protein isolation and purification schemes by affinity chromatography |
| 03/01/2006 | EP1628996A2 Imageable animal model of sars infection |
| 03/01/2006 | EP1628675A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 03/01/2006 | EP0981364B1 Method and compositions for treating hyperlipidemia |
| 03/01/2006 | CN1741741A Composition and method for treating lupus nephritis |
| 02/28/2006 | US7005501 Interleukins; muteins; diagnostic kits |
| 02/28/2006 | US7005420 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 02/28/2006 | US7005411 Method for modulating nerve cell function |
| 02/24/2006 | CA2516876A1 Antibodies which are directed against the marburg i polymorphism of factor vii-activating protease (fsap), and their preparation and use |
| 02/23/2006 | US20060041108 Renilla reniformis green fluorescent protein |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060040272 Composition comprising library of double stranded nucleic acids |
| 02/23/2006 | US20060040271 Processes for detecting or quantifying more than one nucleic acid in a library |
| 02/23/2006 | US20060040270 Processes for detecting or quantifying more than one nucleic acid in library |
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/22/2006 | CN1738643A Composition and method for preventing or treating a virus infection |
| 02/22/2006 | CN1738640A Interferon-alpha polypeptides and conjugates |
| 02/22/2006 | CN1243022C Biologically modified and recombinant human growth hormone compound and preparing method thereof |
| 02/21/2006 | US7002004 Biomolecule and/or cellular arrays on metal surfaces |
| 02/21/2006 | US7001989 Conjugates comprising two active agents |
| 02/21/2006 | US7001715 Hemoglobulin blood substitute |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035389 Immobilization of glycorproteins |